Alnylam Pharmaceuticals, Inc. (ALNY) Return on Equity (ROE) and Return on Assets (ROA)
Alnylam Pharmaceuticals, Inc. (ALNY) return on equity (ROE) and return on assets (ROA) history. Calculate ROE/ROA in Excel with MarketXLS.
ROE & ROA Data
| Period | ROE | ROA |
|---|---|---|
| 2016-12-31 | -44.57% | -32.48% |
| 2017-12-31 | -27.79% | -24.61% |
| 2018-12-31 | -58.49% | -48.36% |
| 2019-12-31 | -61.59% | -37.00% |
| 2020-12-31 | -84.46% | -25.19% |
| 2021-12-31 | -144.99% | -23.41% |
| 2022-12-31 | N/A | -31.90% |
| 2023-12-31 | N/A | -11.49% |
| 2024-12-31 | -414.62% | -6.56% |
| 2025-12-31 | 39.76% | 6.32% |
Return on equity divides net income by total shareholder equity at the period end. Return on assets divides the same net income by total assets at the period end. A figure reads N/A when the divisor is missing or not positive, because the ratio is not meaningful then.
Get Alnylam Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Return_on_Average_Equity("ALNY", 2025, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ALNY | $227.02 | -2.43% | 0.92M |
| 3 | ||||
| 4 | ||||
| 5 |